(Q40088550)

English

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

scientific article published on 19 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

steatohepatitis

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Stefano Ballestri

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Fabio Nascimbeni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Dante Romagnoli

3

object named as

Dante Romagnoli

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

30 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1074-1087

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

From NAFLD in clinical practice to answers from guidelines

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Management of fatty liver disease with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

A myriad of pathways to NASH.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Alanine aminotransferase-old biomarker and new concept: a review

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Apolipoprotein synthesis in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12656

21 January 2018

Identifiers

10.1111/HEPR.12656

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785389%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40088550&oldid=1988617261"